{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:29:34Z","timestamp":1794349774206,"version":"4.9.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ijbiomac.2023.126471","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:17:11Z","timestamp":1692670631000},"page":"126471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine"],"prefix":"10.1016","volume":"252","author":[{"given":"Surbhi","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.126471_bb0005","author":"Yasaei"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0010","author":"ADHD Guide"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0015","doi-asserted-by":"crossref","first-page":"1066988","DOI":"10.3389\/fphar.2022.1066988","article-title":"Treatment of ADHD: drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials","volume":"13","author":"Nazarova","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126471_bb0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0030","first-page":"6564585","article-title":"Blood-brain barrier overview: structural and functional correlation","volume":"6","author":"Alahmari","year":"2023","journal-title":"Neural Plast."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126471_bb0035","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0040","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9 Suppl 3(Suppl 3)","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.126471_bb0045","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier","volume":"13","author":"Lee","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0050","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40204-020-00139-y","article-title":"Recent advances in the formulation of PLGA microparticles for controlled drug delivery","volume":"9","author":"Lagreca","year":"2020","journal-title":"Prog. Biomater."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.126471_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2012.08.006","article-title":"Development and evaluation of sustained-release clonidine-loaded PLGA microparticles","volume":"437","author":"Gaignaux","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126471_bb0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2174\/1570159X20666220706121412","article-title":"Nanocarrier-based drug delivery to brain: interventions of surface modification","volume":"21","author":"Sharma","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126471_bb0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cbin.10459","article-title":"Effect of the surface modification, size, and shape on cellular uptake of nanoparticles","volume":"39","author":"Salatin","year":"2015","journal-title":"Cell Biol. Int."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.126471_bb0075","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/17425247.2019.1690452","article-title":"In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles","volume":"16","author":"Cayero-Otero","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.126471_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine a to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease","volume":"1","author":"Meng","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s13346-022-01220-8","article-title":"Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model","volume":"13","author":"Sandbhor","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.126471_bb0090","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126471_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics14010185","article-title":"Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain","volume":"14","author":"Teixeira","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126471_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","article-title":"Transferrin and transferrin receptors update","volume":"133","author":"Kawabata","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126471_bb0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2011.11.009","article-title":"Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen","volume":"158","author":"Mann","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126471_bb0115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1080\/21691401.2020.1850465","article-title":"Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells","volume":"48","author":"Halder","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126471_bb0120","first-page":"152","article-title":"Development and validation of simple and rapid UV spectroscopic method for estimation of clonidine hydrochloride in tablet dosage form","volume":"10","author":"Bagul","year":"2023","journal-title":"JETIR"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126471_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.18869\/acadpub.pbr.1.4.48","article-title":"Method validation of clonidine hydrochloride in human plasma by LC-MS technique","volume":"1","author":"Danafar","year":"2015","journal-title":"Pharm. Biomed. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126471_bb0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2015.10.057","article-title":"Double emulsion solvent evaporation techniques used for drug encapsulation","volume":"496","author":"Iqbal","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"155","key":"10.1016\/j.ijbiomac.2023.126471_bb0135","article-title":"Synthesis and characterizations of gentamicin-loaded poly-lactic-co-glycolic (PLGA) nanoparticles","volume":"23","author":"Sun","year":"2021","journal-title":"J. Nanopart. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126471_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13346-019-00622-5","article-title":"Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles","volume":"9","author":"Nigam","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0145","doi-asserted-by":"crossref","unstructured":"S. Sharma, S.Dang, Paroxetine loaded PLGA nanoparticles, Mater. Today Proc., 28(1) (2020) 205\u2013210. ndoi:https:\/\/doi.org\/10.1016\/j.matpr.2020.01.568.","DOI":"10.1016\/j.matpr.2020.01.568"},{"issue":"72","key":"10.1016\/j.ijbiomac.2023.126471_bb0150","article-title":"Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy","volume":"22","author":"Scheeren","year":"2020","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00458","article-title":"Formulation and in vitro interaction of rhodamine-B loaded PLGA nanoparticles with cardiac myocytes","volume":"7","author":"Jonderian","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126471_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/21691401.2021.1939709","article-title":"Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study","volume":"49","author":"Shah","year":"2021","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10904-020-01746-9","article-title":"Bioformulated hesperidin-loaded PLGA nanoparticles counteract the mitochondrial-mediated intrinsic apoptotic pathway in cancer cells","volume":"31","author":"Balakrishnan","year":"2021","journal-title":"J. Inorg. Organomet. Polym."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0170","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jddst.2019.05.026","article-title":"Rapamycin-loaded polysorbate 80-coated PLGA nanoparticles: optimization of formulation variables and in vitro anti-glioma assessment","volume":"52","author":"Escalona-Rayo","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.126471_bb0175","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/jbm.a.36145","article-title":"Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier","volume":"105","author":"Ghadiri","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jbiotec.2021.03.010","article-title":"Transferrin-functionalized lipid nanoparticles for curcumin brain delivery","volume":"331","author":"Neves","year":"2021","journal-title":"J. Biotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.126471_bb0185","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1016\/j.sjbs.2021.05.025","article-title":"Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines","volume":"28","author":"Alshetaili","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0190","article-title":"Paclitaxel\/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: formulation development and in vitro antitumor activity evaluation","volume":"256","author":"Madani","year":"2018","journal-title":"Life Sci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2023.126471_bb0195","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/IJN.S195048","article-title":"Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats","volume":"1","author":"Anwer","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.126471_bb0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijpharm.2014.07.022","article-title":"Topotecan\u2013tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential","volume":"473","author":"Khuroo","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molliq.2017.07.002","article-title":"Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: optimization, in vitro characterization and stability assessment","volume":"242","author":"Verma","year":"2017","journal-title":"J. Mol. Liq."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.126471_bb0210","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126471_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/rej.2018.2119","article-title":"Baclofen-loaded poly (D,L-lactide-Co-glycolic acid) nanoparticles for neuropathic pain management: in vitro and in vivo evaluation","volume":"22","author":"Nigam","year":"2019","journal-title":"Rejuvenation Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126471_bb0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneumeth.2009.11.004","article-title":"Differentiation of mouse Neuro 2A cells into dopamine neurons","volume":"186","author":"Tremblay","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2014.04.014","article-title":"Enhanced bioavailability and intestinal uptake of gemcitabine HCl loaded PLGA nanoparticles after oral delivery","volume":"60","author":"Joshi","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0230","doi-asserted-by":"crossref","unstructured":"S. Tang, A. Wang, X.Yan, L. Chu, X. Yang, Y. Song, K. Sun, X. Yu, R. Liu, Z. Wu, P Xue Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease, Drug Deliv., 26:1, 700\u2013707, DOI:https:\/\/doi.org\/10.1080\/10717544.2019.1636420.","DOI":"10.1080\/10717544.2019.1636420"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0235","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ijbiomac.2018.05.079","article-title":"Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: characterization, nasal absorption, histopathology and cell line study","volume":"116","author":"Khan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2014.06.024","article-title":"Surface modified PLGA nanoparticles for brain targeting of Bacoside-A","volume":"63","author":"Jose","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126471_bb0245","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/02652048.2016.1242666","article-title":"Polysorbate-80-coated, polymeric curcumin nanoparticles for in vivo anti-depressant activity across BBB and envisaged biomolecular mechanism of action through a proposed pharmacophore model","volume":"33","author":"Yusuf","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0250","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.2147\/IJN.S109088","article-title":"Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression","volume":"11","author":"He","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126471_bb0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000443575","article-title":"The antidepressant effect of L-tyrosine-loaded nanoparticles: behavioral aspects","volume":"23","author":"Alabsi","year":"2016","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actbio.2015.06.027","article-title":"Surface engineered polymeric nanocarriers mediate the delivery of transferrin\u2013methotrexate conjugates for an improved understanding of brain cancer","volume":"24","author":"Jain","year":"2015","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126471_bb0265","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3892\/ol.2014.2840","article-title":"Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer","volume":"9","author":"Guo","year":"2015","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126471_bb0270","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2010.02.008","article-title":"Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7\u03b1-APTADD to breast cancer cells","volume":"390","author":"Zheng","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0275","first-page":"177","article-title":"Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability","volume":"8","author":"Neves","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0280","first-page":"30","article-title":"Recent biomedical applications and patents on biodegradable polymer-PLGA","volume":"1","author":"Singh","year":"2014","journal-title":"Int. J. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0285","article-title":"Structural aspects of lactoferrin and serum transferrin observed by FTIR spectroscopy","volume":"13","author":"Lilia","year":"2018","journal-title":"Chem. J. Moldova"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126471_bb0290","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","article-title":"Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins","volume":"13","author":"Gabold","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126471_bb0295","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.xphs.2018.07.013","article-title":"Intranasal drug delivery of frovatriptan succinate-loaded polymeric nanoparticles for brain targeting","volume":"108","author":"Deepika","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.126471_bb0300","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier","volume":"13","author":"Lee","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2023.126471_bb0305","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","article-title":"Targeted drug delivery to the brain via intranasal nanoemulsion: available proof of concept and existing challenges","volume":"565","author":"Chatterjee","year":"2019","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023033676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023033676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:27:01Z","timestamp":1758882421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023033676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":61,"alternative-id":["S0141813023033676"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126471","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126471"}}